PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1597861-9 1992 With sex steroid binding protein, a human serum binding protein, the pattern of binding affinities is nearly the reverse, with derivatives of Mib, R1881 and MNT having low affinity, and DHT and T, high affinity. Dihydrotestosterone 186-189 growth hormone receptor Homo sapiens 42-63 14678285-0 2004 The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration. Dihydrotestosterone 190-209 growth hormone receptor Homo sapiens 86-97 14678285-1 2004 OBJECTIVE: The study describes for the first time, a homozygous mutation in the WSXWS-like motif of the human GH receptor (GHR) in a patient with Laron syndrome and describe laboratory data during treatment with GnRHa to suppress puberty and dihydrotestosterone (DHT). Dihydrotestosterone 242-261 growth hormone receptor Homo sapiens 110-121 14678285-1 2004 OBJECTIVE: The study describes for the first time, a homozygous mutation in the WSXWS-like motif of the human GH receptor (GHR) in a patient with Laron syndrome and describe laboratory data during treatment with GnRHa to suppress puberty and dihydrotestosterone (DHT). Dihydrotestosterone 242-261 growth hormone receptor Homo sapiens 123-126 14678285-1 2004 OBJECTIVE: The study describes for the first time, a homozygous mutation in the WSXWS-like motif of the human GH receptor (GHR) in a patient with Laron syndrome and describe laboratory data during treatment with GnRHa to suppress puberty and dihydrotestosterone (DHT). Dihydrotestosterone 263-266 growth hormone receptor Homo sapiens 110-121 14678285-1 2004 OBJECTIVE: The study describes for the first time, a homozygous mutation in the WSXWS-like motif of the human GH receptor (GHR) in a patient with Laron syndrome and describe laboratory data during treatment with GnRHa to suppress puberty and dihydrotestosterone (DHT). Dihydrotestosterone 263-266 growth hormone receptor Homo sapiens 123-126 8969286-11 1996 The decline in GHBP with T treatment was apparently due to an androgen receptor-dependent mechanism, since the same effect was seen during treatment with the nonaromatizable androgen, DHT. Dihydrotestosterone 184-187 growth hormone receptor Homo sapiens 15-19